Product Code: ETC066706 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Singapore Infectious Disease Point-of-care Testing Market plays a critical role in providing quick and accurate diagnoses of infectious diseases. POCT devices for infectious diseases include rapid diagnostic tests (RDTs) for conditions like malaria, influenza, HIV, COVID-19, and other communicable diseases.
Timely Diagnoses and Treatment: POCT allows healthcare providers to diagnose infectious diseases quickly, enabling early initiation of appropriate treatment and containment measures.Convenience and Accessibility: Point-of-care testing provides easy access to testing, especially in remote or underserved areas, where centralized laboratory facilities may be limited.Outbreak Management: In the case of infectious disease outbreaks, such as COVID-19, the adoption of POCT devices helps in rapid screening and monitoring to contain the spread.
Quality and Accuracy: Ensuring the accuracy and reliability of POCT devices is essential to avoid false-positive or false-negative results, which may impact patient management and public health efforts.Regulatory Compliance: POCT devices must meet regulatory standards to ensure patient safety and compliance with local health authorities.Cost and Affordability: The cost of POCT devices and kits may be a challenge, especially for resource-limited settings, and could influence their widespread adoption.
Abbott Laboratories, Roche Diagnostics, Quidel Corporation, BD (Becton, Dickinson and Company), Cepheid Inc. (a subsidiary of Danaher Corporation) are the key players in the market.
The Covid-19 pandemic had a significant impact on the Singapore Infectious Disease Point-of-care Testing Market. The demand for POCT devices, especially COVID-19 rapid tests, increased during the pandemic as they played a crucial role in screening and detecting infections in community settings, workplaces, and healthcare facilities.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Infectious Disease Point-of-care Testing Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, 2020 & 2027F |
3.3 Singapore Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Singapore Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2020 & 2027F |
3.6 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2020 & 2027F |
3.7 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2020 & 2027F |
4 Singapore Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Singapore Infectious Disease Point-of-care Testing Market Trends |
6 Singapore Infectious Disease Point-of-care Testing Market, By Types |
6.1 Singapore Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2018 - 2027F |
6.1.3 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2018 - 2027F |
6.1.4 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2018 - 2027F |
6.1.5 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2018 - 2027F |
6.1.6 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2018 - 2027F |
6.1.7 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 Singapore Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2018 - 2027F |
6.2.3 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2018 - 2027F |
6.2.4 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2018 - 2027F |
6.2.5 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2018 - 2027F |
6.3 Singapore Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2018 - 2027F |
6.3.3 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2018 - 2027F |
6.3.4 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2018 - 2027F |
6.3.5 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2018 - 2027F |
7 Singapore Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Singapore Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Singapore Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Singapore Infectious Disease Point-of-care Testing Market Key Performance Indicators |
9 Singapore Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Singapore Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2020 & 2027F |
9.2 Singapore Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2020 & 2027F |
9.3 Singapore Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2020 & 2027F |
10 Singapore Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Singapore Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2020 |
10.2 Singapore Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |